Key Drivers
- Elite margins
- Strong cash flow
- Tight liquidity
AIAI Summary
IDXX is now best viewed as a high-quality recurring-revenue compounder with strong operating momentum and durable cash generation, but the main investment issue is valuation—so the stock looks more attractive on pullbacks or only after a decisive breakout above 560–565, not as a chase at current levels.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Elite margins
- •Strong cash flow
- •Tight liquidity
IDXX delivers elite profitability and cash generation with strong interest coverage, but its tighter liquidity and premium valuation make the stock appealing on quality and cautious on price.
Price Behavior
Key Price Behavior Insights:
- •Choppy action
- •Sharp rebound
- •Key resistance
Over the last month, IDXX was choppy and slightly weaker overall, rebounded sharply from late-June lows, but still needs a decisive close above $560-$565 to confirm the downtrend has ended.
Sharp rebound from $526.44 on 2026-06-30 to $557.80 by 2026-07-02 suggests short-term recovery
Sentiment & News
Key News Insights:
- •Growth Momentum
- •Options Activity
- •Earnings Ahead
IDEXX remains a positive growth/momentum story with strong style scores and a high GF Score, though the mid-June dip and options activity suggest traders are positioning ahead of its Aug. 4 earnings report.
The news flow is supportive overall and keeps IDEXX in focus as a growth stock, with near-term attention likely centered on the upcoming earnings release
Similar Companies in Healthcare
Other companies in the same sector with AI ratings